<p>
<strong>The Serum Institute of India (SII) on Saturday broke its silence over the pricing of its Covid-19 vaccine &#39;Covishield&#39; and said that it is the most affordable vaccine available in the market today.</strong></p>
<p>
SII, which manufactures the AstraZeneca vaccine Covishield at its Pune facility, said that the initial prices were kept very low globally as it was based on advance funding given by the countries for at-risk vaccine manufacturing.<br />
<br />
The initial supply price of the vaccine for all government immunisation programmes, including in India, was the lowest, it said.<br />
<br />
&quot;The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat Covid-19 and other life-threatening diseases,&quot; Adar C. Poonawalla, Chief Executive Officer, SII, said in a statement.<br />
<br />
The company also said that only a limited portion of Sll&#39;s volume will be sold to private hospitals at Rs 600 per dose.<br />
<br />
Earlier this week, the company had announced that Covishield will be sold at Rs 400 per dose to the state governments and Rs 600 to the private hospitals.<br />
<br />
The Indian biotechnology and pharmaceuticals company announced the new prices after the government allowed vaccination for all persons above the age of 18 years from May 1 onwards.<br />
&nbsp;</p>
<p>
<em>(IANS)</em></p>
<p>
&nbsp;</p>
<p>
&nbsp;</p>
<p>
&nbsp;</p>
<p>
&nbsp;</p>
A passenger plane flying from Azerbaijan to Russia crashed near the city of Aktau in…
Union Home and Cooperation Minister Amit Shah on Wednesday dedicated more than 10,000 newly established…
Apple has confirmed that the upcoming iOS 18.2.1 update is in the works for iPhone…
Residents of the Qamri area in Astore district in Pakistan-occupied Gilgit Baltistan(PoGB), are facing a…
A passenger plane travelling from Azerbaijan to southern Russia with 67 people on board crashed…
Prime Minister Narendra Modi on Wednesday inaugurated and laid the foundation stone of multiple development…